Partnering with Pfizer’s CTI: Funding Opportunities and Best Practices for Application Submission
The Office of Technology Commercialization
Invention 2 Innovation (I2I)
“Partnering with Pfizer’s CTI: Funding Opportunities and Best Practices for Application Submission”
Pfizer’s Center for Therapeutic Innovation (CTI) offers multiple and diverse funding vehicles to suit researchers’ needs to help develop early-stage science into breakthrough medicines for patients. Pfizer’s CTI focuses on accessing cutting-edge science and innovative discoveries aligned with Pfizer’s current core research areas of Oncology, Inflammation & Immunology, Rare Diseases, and Internal Medicine with a strategic focus on the emerging areas of Senescence, Repeat Expansion Disorders and DNA Damage Response. The talk will focus on the upcoming funding opportunities for the researchers, the application submission process, and best practices for successful grant applications.
Thursday, 18 November 2021
11:00 am – 12:00 pm
Barbara Sosnowski, Ph.D.
Vice President and Global Head of Emerging Science & Innovation Lead
Interested faculty, staff, postdocs, clinicians, undergraduate, and graduate students, and entrepreneurs should attend.